High Cholesterol

References

Citations

1. Grundy SM, et al. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285(19): 2486–2497.

2. Pignone M (2007). Primary prevention: Dyslipidaemia, search date March 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.

3. Gami A (2007). Secondary prevention of ischaemic cardiac events, search date July 2004. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.

4. Grundy SM, et al. (2004). Implications of recent clinical trials of the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 110(2): 227–239. [Erratum in Circulation, 110(6): 763.]

5. Kraus WE, et al. (2002). Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine, 347(19): 1483–1492.

6. Berthold HK, et al. (2006). Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia. JAMA, 295(19): 2262–2269.

Other Works Consulted

• Brunzell JD, Failor RA (2006). Diagnosis and treatment of dyslipidemia. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 11. New York: WebMD.

• Genest J, Libby P (2008). Lipoprotein disorders and cardiovascular disease. In P Libby et al., eds., Braunwald's Heart Disease, 8th ed., vol. 1, pp. 1071–1092. Philadelphia: Saunders Elsevier.

• Kavey RW, et al. (2003). American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation, 107(11): 1562–1566.

• Krummel DA (2008). Medical nutrition therapy for cardiovascular disease. In LK Mahan, S Escott-Stump, eds., Krause's Food and Nutrition Therapy, 12th ed., pp. 833–864. St. Louis: Saunders Elsevier.

• Maron DJ, et al. (2008). Risk factors for which interventions have proved to lower risk of coronary heart disease section of Preventative strategies for coronary heart disease. In V Fuster et al., eds., Hurst's The Heart, 12th ed., pp. 1208–1217. New York: McGraw-Hill.

• Mosca L, et al. (2007). Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation, 115(11): 1481–1501.

• Stone NJ, Blum CB (2004). Management of Lipids in Clinical Practice. Caddo, OK: Professional Communications.

• U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.

• U.S. Preventive Services Task Force (2009). Aspirin for the Prevention of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf/uspsasmi.htm.

Go to previous section	Go to top of page	Go to next section
Author:	Robin Parks, MS	Last Updated: July 11, 2008
Medical Review:	E. Gregory Thompson, MD - Internal Medicine Robert A. Kloner, MD, PhD - Cardiology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.